SCHEMBL29459463

SCHEMBL29459463

c1cc2ccc3ccc4c5c(cc(c1)c2c35)C1OC41

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
HSD17B10 Q99714 5/20 0.46
TSHR P16473 5/20 0.46
HPGD P15428 4/20 0.46
CYP1A2 P05177 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP1A1 P04798 2/20 0.46
CYP1B1 Q16678 2/20 0.46
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.33
THRB P10828 1/20 0.33
AMY1A P0DUB6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15848139 0.77 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRHPGDCYP1A2
SCHEMBL106821 0.74 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1A2
SCHEMBL30867671 0.74 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1A2
SCHEMBL40362 0.74 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1A2
SCHEMBL29524698 0.74 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1A2
SCHEMBL29555052 0.74 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Methane SCHEMBL28210424 0.69 ALDH1A1 (0.65) ALDH1A1HSD17B10TSHRHPGDCYP1A2
SCHEMBL2536328 0.69 ALDH1A1 (0.62) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Pyrene SCHEMBL223412 0.68 ALDH1A1 (1.00) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Pyrene SCHEMBL1332849 0.68 ALDH1A1 (1.00) ALDH1A1HSD17B10TSHRHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12231263-B2 Method and device for advertising information in bridge network and common attributes management component ZTE CORPORATION (CN) 2025-02-18 US claimed
CN-117709636-B Ground energy storage system capacity configuration method, terminal equipment and storage medium 通号(长沙)轨道交通控制技术有限公司 2024-06-25 CN claimed
EP-3958518-B1 INFORMATION ANNOUNCEMENT ON A BRIDGE NETWORK ZTE CORP (CN) 2023-06-21 EP claimed
EP-4114224-A1 PERSONAL PROTECTIVE EQUIPMENT Behzadi, Kambiz (US) 2023-01-11 EP claimed
US-20220368562-A1 METHOD AND DEVICE FOR ADVERTISING INFORMATION IN BRIDGE NETWORK AND COMMON ATTRIBUTES MANAGEMENT COMPONENT ZTE CORPORATION (CN) 2022-11-17 US claimed
CN-113346526-B Multi-node energy storage system configuration method based on discrete-continuous hybrid method 国网综合能源服务集团有限公司 2022-05-20 CN claimed
EP-3958518-A1 BRIDGED NETWORK INFORMATION ANNOUNCEMENT METHOD, DEVICE, AND COMMON ATTRIBUTE MANAGEMENT COMPONENT ZTE Corporation (CN) 2022-02-23 EP claimed
CN-122031361-A Injectable hydrogel with ROS responsiveness as well as preparation method and application thereof 中山大学附属口腔医院 2026-05-15 CN disclosed
EP-4731336-A1 POROUS CARBON AND METHOD FOR THE MANUFACTURE AND USES THEREOF SHPP Global Technologies B.V. (NL) 2026-04-29 EP disclosed
US-12553605-B2 Mercury, dioxin, and furan removal system and method for reducing GAC fires on new high temperature municipal sludge incinerators TAKMAZ LEVENT (US) 2026-02-17 US disclosed
US-20260004586-A1 OPERATIONS AND PERFORMANCE AREA PROTECTIVE EQUIPMENT MONITORING SYSTEM KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-01 US disclosed
US-20250339514-A1 SINGLE-AND MULTI-EPITOPE PEPTIDE AND MRNA VACCINES TO GENERATE TOLEROGENIC EFFECTS FOR ALLERGIC AND AUTOIMMUNE DISEASE BY TARGETING LIVER SINUSOIDAL ENDOTHELIAL CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-06 US disclosed
US-20250261642-A1 POLYMER COACERAVATES AND METHODS OF DISRUPTING AND REMOVING BIOFILMS JOY ABRAHAM (US) 2025-08-21 US disclosed
CN-114929208-A Transdermal penetration by modulation of epithelial junctions 黛芙生物科学公司 2022-08-19 CN disclosed
US-11369922-B2 Catalyst mixture for the treatment of waste gas CPPE CARBON PROCESS & PLANT ENGINEERING S.A. (LU) 2022-06-28 US disclosed
CN-108853510-B Treatment and medicaments for depression with a combination of an NMDAR inhibitor and a T-type calcium channel inhibitor 浙江大学 2022-05-20 CN disclosed
CN-113346526-B Multi-node energy storage system configuration method based on discrete-continuous hybrid method 国网综合能源服务集团有限公司 2022-05-20 CN disclosed
US-20220146946-A1 METHOD FOR CONTROLLING A LITHOGRAPHIC APPARATUS AND ASSOCIATED APPARATUSES ASML NETHERLANDS B.V. (NL) 2022-05-12 US disclosed
CN-111130953-B VNF availability monitoring method, device and medium 奇安信科技集团股份有限公司 2022-04-15 CN disclosed
EP-3958518-A1 BRIDGED NETWORK INFORMATION ANNOUNCEMENT METHOD, DEVICE, AND COMMON ATTRIBUTE MANAGEMENT COMPONENT ZTE Corporation (CN) 2022-02-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260004586-A1 OPERATIONS AND PERFORMANCE AREA PROTECTIVE EQUIPMENT MONITORING SYSTEM PSMA6, PSMA8, PSMC5 ALDH1A1 3698/4885HSD17B10 4662/4885TSHR 2431/4885
US-12553605-B2 Mercury, dioxin, and furan removal system and method for reducing GAC fires on new high temperature municipal sludge incinerators AGL, EIF4G2, EIF4G1 ALDH1A1 3343/4885HSD17B10 2917/4885TSHR 858/4885
US-20250261642-A1 POLYMER COACERAVATES AND METHODS OF DISRUPTING AND REMOVING BIOFILMS COASY, PUF60, VCL ALDH1A1 3561/4885HSD17B10 319/4885TSHR 4744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.